Sharp Edge Labs: Discovering Drugs to Treat Genetic Disorders of Protein Trafficking.

2    View on Facebook
Sharp Edge Labs
Sharp Edge Labs shared University of Pittsburgh's post.Thursday, December 21st, 2017 at 5:01am
Sharp Edge Labs is proud to be a part of the LifeX Initiative!
   View on Facebook
Sharp Edge Labs
Sharp Edge LabsThursday, January 26th, 2017 at 5:50am
Sharp Edge Labs and Cell Guidance Make New Technology Available to Study Exosomes (Important in Cancer Cell Communications)

http://finance.yahoo.com/news/cell-guidance-systems-limited-sharp-173200570.html
4    View on Facebook
Sharp Edge Labs
Sharp Edge LabsWednesday, January 11th, 2017 at 3:46am
Outsourcing Pharma asks us about our collaboration with Sumitomo and we talk a bit about what precision medicine will mean for patients and payers in the future. http://www.outsourcing-pharma.com/Preclinical-Research/Sharp-Edge-Labs-announces-drug-discovery-collab#.WHTinBdKy_o.twitter
3    View on Facebook
Sharp Edge Labs
Sharp Edge LabsWednesday, January 4th, 2017 at 5:05am
Big News for us! We've just anounced a new discovery collaboration in neurodegeneration. http://prn.to/2iLCtS6
22 7    View on Facebook
Off the Shelf
  • Monogenic Diseases
    Caused by a single gene alteration, monogenic diseases represent an area of high unmet need, and also of great therapeutic opportunity.
  • Trafficking Defects
    Many monogenic diseases result from a mutation that causes improper trafficking, the failure of the mutated protein to get to the right place inside the cell.
  • Patient-Driven Discovery
    Stem-Cell technology allows patients to participate in drug discovery programs at their earliest stages.
On the Bench
Sharp Edge Radar